U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

U.S. officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

The US medicines regulator approved a new type of pain pill that aims to eliminate the risks of addiction and overdose associated with medications that launched the US into an opioid epidemic more ...

FDA Approves First New Non-Opioid Pain Pill in Decades By India Edwards HealthDay Reporter FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved ...

Studies show it is more effective than a placebo but does not outperform traditional opioid-acetaminophen pain relievers. Journavx will cost $15.50 per pill—significantly more than generic ...

The U.S. Food and Drug Administration announced that it has approved a new non-opioid painkiller pill from Vertex Pharmaceuticals called suzetrigine, which is being sold under the name Journavx.

The US medicines regulator approved a new type of pain pill that aims to eliminate the risks of addiction and overdose associated with medications that launched the US into an opioid epidemic more ...

Opens in a new tab or window The FDA approved prescription suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults ...

It's the first new non-opioid pain pill in over two decades The drug blocks pain signals before they reach the brain, avoiding opioid risks FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food ...